Catabasis Pharmaceuticals Inc (CATB): Deerfield Management Adds to Its Position

Page 7 of 12

Page 7 of 12 – SEC Filing
CUSIP No.
14875P107
13G
Page 7 of 9
(i)    o A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
(j)    o
A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
 
k)    o
Group, in accordance with Rule 13d-1(b)(1)(ii)(K).
 
If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: _________________
 
Item 4.      Ownership. 
 
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
 
(a)
Amount beneficially owned**:
Deerfield Mgmt, L.P. –  783,375 shares
Deerfield Management Company, L.P. –  783,375 shares
Deerfield Special Situations Fund, L.P. –  783,375 shares
James E. Flynn –  783,375 shares
(b)
Percent of class**:
Deerfield Mgmt, L.P. – 4.21%
Deerfield Management Company, L.P. – 4.21%
Deerfield Special Situations Fund, L.P. – 4.21%
James E. Flynn – 4.21%
 
(c)
Number of shares as to which such person has**:
(i)
Sole power to vote or to direct the vote
All Reporting Persons – 0
(ii)
Shared power to vote or to direct the vote
Deerfield Mgmt, L.P. –  783,375 shares
Deerfield Management Company, L.P. –  783,375 shares
Deerfield Special Situations Fund, L.P. –  783,375 shares
James E. Flynn –  783,375 shares
      
(iii)
Sole power to dispose or to direct the disposition of
All Reporting Persons – 0
(iv)
Shared power to dispose or to direct the disposition of
Deerfield Mgmt, L.P. –  783,375 shares
Deerfield Management Company, L.P. –  783,375 shares
Deerfield Special Situations Fund, L.P. –  783,375 shares
James E. Flynn –  783,375 shares
 
**See footnotes on cover pages which are incorporated by reference herein.
 

Follow Astria Therapeutics Inc. (NASDAQ:ATXS)

Page 7 of 12